Use of Lactulose to Treat Hyperammonemia in ICU Patients Without Chronic Liver Disease or Significant Hepatocellular Injury.

MLA

Cutler, Nathan S., et al. “Use of Lactulose to Treat Hyperammonemia in ICU Patients Without Chronic Liver Disease or Significant Hepatocellular Injury.” Journal of Intensive Care Medicine, vol. 37, no. 5, May 2022, pp. 698–706. EBSCOhost, https://doi.org/10.1177/08850666211023004.

APA

Cutler, N. S., Sadowski, B. W., & MacGregor, D. A. (2022). Use of Lactulose to Treat Hyperammonemia in ICU Patients Without Chronic Liver Disease or Significant Hepatocellular Injury. Journal of Intensive Care Medicine, 37(5), 698–706. https://doi.org/10.1177/08850666211023004

Chicago

Cutler, Nathan S, Brett W Sadowski, and Drew A MacGregor. 2022. “Use of Lactulose to Treat Hyperammonemia in ICU Patients Without Chronic Liver Disease or Significant Hepatocellular Injury.” Journal of Intensive Care Medicine 37 (5): 698–706. doi:10.1177/08850666211023004.